ATTRV30M amyloidosis Advocacy Hub | UniteRare

At a Glance

Live from database

🩺

15Specialists

📰

1Recent news

Regulatory Watchboard

No FDA or trial events recorded yet for ATTRV30M amyloidosis.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for ATTRV30M amyloidosis.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for ATTRV30M amyloidosis.
Search all trials →

Search clinical trials for ATTRV30M amyloidosis →

Recent News & Research

1 article

AlnylamFeb 5, 2026

Alnylam Reports Record $2.8B Revenue from RNAi Portfolio

Alnylam reported $2.8 billion from RNA interference therapies for hereditary ATTR and other rare diseases.

Read ↗

Browse all ATTRV30M amyloidosis news →

Specialist Network

Top 6 by expertise

Ana Paula Sousa, R.D.H

Centro Hospitalar Universitário de Santo António

📍 RANDOLPH, MA

Score 01 pub

Cristina Alves

Centro Hospitalar Universitário de Santo António

📍 FRAMINGHAM, MA

Score 01 pub

Márcio Neves Cardoso

Centro Hospitalar Universitário de Santo António

Score 01 pub

Armando Teixeira-Pinto

The University of Sydney

Score 01 pub

Maria Pedroto

Laboratory of Artificial Intelligence and Decision Support (LIAAD

Score 01 pub

Ana Martins da Silva

Abel Salazar Biomedical Sciences Institute

Score 01 pub

View all ATTRV30M amyloidosis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰